Results 11 to 20 of about 7,774 (176)

Zanubrutinib-induced aseptic meningitis: a case report and literature review

open access: yesFrontiers in Pharmacology, 2023
Zanubrutinib is a Bruton tyrosine kinase (BTK) inhibitor used in B cell malignancy treatment and is generally well tolerated in most patients. Zanubrutinib-induced aseptic meningitis is currently not reported.
Jinjun Yang   +4 more
doaj   +1 more source

Drug-induced aseptic meningitis

open access: yesTidsskrift for Den norske legeforening, 2023
Drug-induced aseptic meningitis is a rare but serious condition that should be suspected in patients with meningitis who test negative for a microbiological agent. The medical history is presented here of a woman with recurrent urinary tract infections where meningitis symptoms arose after repeated exposure to a frequently prescribed drug.
Camilla, Ågnes   +6 more
openaire   +2 more sources

Aseptic meningitis, hepatitis and cholestasis induced by trimethoprim/sulfamethoxazole: a case report

open access: yesBMC Pediatrics, 2021
Background Drug-induced aseptic meningitis is a rare, but challenging diagnosis, most commonly reported with nonsteoroidal anti-inflammatory drugs (NSAIDs) and antibiotics.
J. A. A. van Asperdt, R. A. De Moor
doaj   +1 more source

Chemical‐induced aseptic meningitis as a result of intrathecal hydromorphone therapy: Case report

open access: yesClinical Case Reports, 2021
Chemical meningitis, though rare, is a diagnosis of exclusion that must be considered in patients presenting with neurologic symptoms of undetermined cause. It is likely that any substance in contact with CSF can be the culprit.
Sydney Willhite, Sangeeta Juloori
doaj   +1 more source

Ibuprofen-Induced Aseptic Meningitis in a Male Adolescent with Intracranial Hypertension and Visual Impairment: A Case Report

open access: yesCase Reports in Neurology, 2021
Drug-induced aseptic meningitis (DIAM) is a rare complication of certain drugs, most commonly reported with ibuprofen use. The present study reports on a male adolescent with intracranial hypertension and visual impairment accompanied by DIAM. We present
Seyed Mohammad Mousavi Mirzaei   +1 more
doaj   +1 more source

Amoxicillin-induced Aseptic Meningitis

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2020
Amoxicillin is a semi synthetic beta-lactam antibiotic that belongs to the penicillin family. It is the most prescribed antibiotic in the world. It has few side effects, even though hypersensitivity reactions may occur, with potential life-threatening ...
Débora Sousa, Pedro Raimundo
doaj   +1 more source

Cetuximab-Induced Aseptic Meningitis in a Patient with Colorectal Cancer: A Case Report and Review of Literature

open access: yesCase Reports in Neurology, 2022
Cetuximab is a chimeric IgG1 monoclonal antibody against epidermal growth factor receptor. It is approved by the European medical agency for the treatment of RAS wild-type metastatic colorectal cancer and metastatic squamous cell cancer of the head and ...
Jakob Jäger   +7 more
doaj   +1 more source

The Challenge of Drug-Induced Aseptic Meningitis [PDF]

open access: yesArchives of Internal Medicine, 1999
Several drugs can induce the development of aseptic meningitis. Drug-induced aseptic meningitis (DIAM) can mimic an infectious process as well as meningitides that are secondary to systemic disorders for which these drugs are used. Thus, DIAM constitutes a diagnostic and patient management challenge.
G, Moris, J C, Garcia-Monco
openaire   +2 more sources

Amoxicillin-induced aseptic meningitis: clinical features, diagnosis and management

open access: yesEuropean Journal of Medical Research, 2023
Objectives The clinical features of aseptic meningitis associated with amoxicillin are unknown. The main objective of this study was to investigate the clinical characteristics of amoxicillin-induced aseptic meningitis (AIAM) and provide a reference for ...
Zhiqiang Fan   +5 more
doaj   +1 more source

Cetuximab-induced aseptic meningitis: case report and review of a rare adverse event. [PDF]

open access: yes, 2016
BACKGROUND: Cetuximab is a commonly used antibody agent in the treatment of colorectal or head and neck cancer. Although it is generally well tolerated in most patients, cetuximab has been associated with some rare but serious adverse events.
Baba-Hamed, N.   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy